 WESTON, Fla., Feb. 26, 2021 PRNewswire -- Cantex Pharmaceuticals, Inc., a clinical stage biopharmaceutical company developing proprietary pharmaceuticals for the treatment of inflammatory lung diseases and cancer, today announced that Chimerix, Inc. NASDAQ:CMRX, worldwide licensee of... 